![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Receives Funding Commitment
08 avr. 2010 10h43 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 8, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Launches $250,000,000 Lawsuit Against TheStreet.com and Feuerstein
06 avr. 2010 11h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., April 6, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces Expansion Plan for the U.S. FDA Expanded Access Treatment IND Program for Generex Oral-lyn(TM) in the United States
29 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 29, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Demands Retraction of False and Misleading Article
23 mars 2010 08h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 23, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) has demanded a retraction of and apologies for the inaccuracies in an online...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Oral-lyn(TM) Presentation at CODHy Congress
16 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 16, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Receives Positive Responses From Independent Physicians and Nurse Practitioners in Recent Focus Groups Conducted in the United States for Generex Oral-lyn(TM)
11 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 11, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Establishes Key Strategic Relationships for the Development of a Distribution Network for Generex Oral-lyn(R) Under the FDA's Expanded Access Treatment IND Program
04 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 4, 2010 (GLOBE NEWSWIRE) -- In September of 2009, Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Subsidiary Antigen Express Receives Patent in China for Its Ii-Key Peptide Vaccine Technology
02 mars 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., March 2, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com) today announced that it has received notice of issuance of a patent in respect of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Announces Participation in 2010 Arab Health Congress
25 janv. 2010 09h30 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 25, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...
![Generex Biotechnology Corp. Logo](/news-release/logo/216771/0/216771.jpg?lastModified=12%2F09%2F2016%2022%3A59%3A49&size=2)
Generex Biotechnology Highlights OTC Product Line at The Vitamin, Diet & Sports Nutrition Efficient Program Planning Session
20 janv. 2010 10h03 HE
|
Generex Biotechnology Corp.
WORCESTER, Mass., Jan. 20, 2010 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of...